查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654158

数位糖尿病管理市场规模、份额、趋势分析报告：按产品类型、最终用途、地区和细分市场预测，2025-2030 年

Digital Diabetes Management Market Size, Share & Trends Analysis Report By Product (Continuous Glucose Monitoring System, Smart Insulin Pen), By Type (Wearable, Handheld Device), By End-use (Hospitals), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

数位糖尿病管理市场的成长和趋势

根据Grand View Research, Inc.的最新报告，全球数位糖尿病管理市场规模预计到2030年将达到219亿美元，2025年至2030年期间的复合年增长率为8.7%。

推动市场成长的关键因素是全球糖尿病盛行率的不断上升、产品推出数量的不断增加以及预测分析和人工智慧（AI）等技术进步。

资料分析和人工智慧现在已成为糖尿病患者数位解决方案不可或缺的一部分。人工智慧因其利用大量患者资讯的能力而迅速受到关注。数位化糖尿病管理工具可帮助患者分析他们的血糖浓度和模式。它还可以帮助患者确定食物摄取量和胰岛素剂量。过去几年，用于疾病管理的智慧型手机应用程式的数量呈指数级增长，为市场提供了巨大的推动力。例如，2019 年 9 月，雅培与赛诺菲达成非独家伙伴关係关係，将其云端连接胰岛素笔（赛诺菲）与 FreeStyle Libre 行动应用程式（雅培）相结合，以简化糖尿病管理流程。

肥胖症盛行率的上升、人口老化加剧以及糖尿病预防保健意识的增强进一步推动了市场的成长。此外，有效用户数量的增加，以及允许患者监测血糖值的新应用程式的推出也推动了市场的发展。这些应用程式为医疗专业人员提供先进的技术，并为患者提供更好的健康结果。 2019 年 5 月，罗氏糖尿病护理印度公司在印度推出了综合糖尿病管理解决方案 (IDMS) 计划，并推出了 Accu-Chek 即时血糖监测 (BGM) 系统和 My Sugar 应用程式。这一组合标誌着下一代BGM系统的到来。预计这将刺激产品需求并推动该国整体市场的发展。

数位糖尿病管理市场报告重点

  • 持续血糖监测系统领域在 2024 年占据市场主导地位，份额为 40.4%。 CGM 系统提供即时血糖跟踪，为 1 型和 2 型糖尿病的管理提供重要见解。
  • 预计穿戴式装置领域将在 2024 年占据最大的市场占有率，并且由于对便利性、持续监控和即时资料追踪的需求不断增加，预计也将以最快的速度成长，预测期内复合年增长率为 8.9%。
  • 2024 年，医院部门占据市场主导地位，份额为 41.5%。医院仍然是严重或复杂糖尿病患者进行诊断测试、进阶治疗和监测的主要场所。
  • 2024 年北美数位糖尿病管理市场占有最大份额，为 38.2%。这一优势可归因于主要市场参与企业的存在以及该地区糖尿病盛行率的上升。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章数位糖尿病管理市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 数位糖尿病管理市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析

第 4 章数位糖尿病管理市场：产品、估计与趋势分析

  • 细分仪表板
  • 全球数位化糖尿病管理产品市场趋势分析
  • 2018 年至 2030 年全球数位糖尿病管理市场规模与趋势分析（按产品划分）
  • 智慧型血糖值仪
  • 持续血糖监测系统
  • 智慧胰岛素笔
  • 智慧型胰岛素帮浦/闭合迴路系统
  • 应用程式

第 5 章。

  • 细分仪表板
  • 全球数位化糖尿病管理市场趋势分析
  • 2018 年至 2030 年全球数位糖尿病管理市场规模与趋势分析（按类型）
  • 穿戴式装置
  • 手持装置

6. 数位糖尿病管理市场：最终用途、估计和趋势分析

  • 细分仪表板
  • 全球数位糖尿病管理终端用途市场趋势分析
  • 2018 年至 2030 年全球数位糖尿病管理市场规模及趋势分析（依最终用途）
  • 医院
  • 居家医疗
  • 诊断中心

第 7 章数位糖尿病管理市场：按产品、类型、最终用途和地区进行的估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 市场规模、预测趋势分析，2018-2030
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 2024 年主要企业的市场占有率分析
  • Company Position Analysis
  • 公司分类（新兴企业、创新企业、领导者）
  • 公司简介
    • Abbott
    • Medtronic
    • F. Hoffmann-La Roche Ltd.
    • Bayer AG
    • LifeScan, Inc.
    • Dexcom, Inc.
    • Sanofi
    • Insulet Corporation
    • Ascensia Diabetes Care Holdings AG
    • B. Braun Melsungen AG
Product Code: GVR-3-68038-689-9

Digital Diabetes Management Market Growth & Trends:

The global digital diabetes management market size is expected to reach USD 21.9 billion by 2030, registering a CAGR of 8.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Major factors contributing to the market growth are the growing incidences of diabetes globally, the increasing number of product launches, and innovation in technologies such as predictive analytics and artificial intelligence (AI).

Data analytics and artificial intelligence are now an integral part of digital solutions for diabetics. AI is gaining rapid attention due to its ability to harness massive volumes of patient information. Digital diabetes management tools help patients analyze their glucose levels and pattern. They also help patients decide on food intake and dosage of insulin. The number of smartphone apps for disease management has seen a monumental rise over the past few years, giving the market a major boost. For instance, in September 2019, Abbott entered into a non-exclusive partnership with Sanofi to integrate cloud-connected insulin pens (Sanofi) with FreeStyle Libre mobile application (Abbott) to ease the management process of diabetes.

The market growth is further augmented by the increasing prevalence of obesity, the growing aging population, and increasing awareness regarding diabetes preventive care. Moreover, the market is driven by the increasing number of active users of smart devices and the launch of new apps that allow patients to monitor their blood glucose. These apps use advanced technology for health care professionals and provide patients with better health outcomes. In May 2019, Roche Diabetes Care India introduced its Integrated Diabetes Management Solution (IDMS) program in India with the launch of the Accu-Chek Instant blood glucose monitoring (BGM) system and the My Sugar app. The combination marks the entry of the next-generation BGM system. This is expected to propel the demand for the product, thereby driving the overall market in the country.

Digital Diabetes Management Market Report Highlights:

  • The continuous glucose monitoring systems segment dominated the market by capturing a share of 40.4% in 2024. CGM systems offer real-time glucose tracking, providing critical insights for both Type 1 and Type 2 diabetes management.
  • The wearable devices segment held the largest market share in 2024 and is also expected to grow at the fastest CAGR of 8.9% over the forecast period, driven by the increasing demand for convenience, continuous monitoring, and real-time data tracking.
  • The hospital segment dominated the market by capturing a share of 41.5% in 2024. Hospitals remain the primary setting for diagnostic testing, advanced treatments, and monitoring for patients with severe or complex diabetes.
  • North America digital diabetes management market held the largest share of 38.2% in 2024. This dominance is driven by the presence of leading market players in the region and the increasing prevalence of diabetes.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Type outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Digital Diabetes Management Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of diabetes
      • 3.2.1.2. Growing use of wearable devices for glucose monitoring
      • 3.2.1.3. Increasing awareness about diabetes management
      • 3.2.1.4. Supportive government initiatives and reimbursement policies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High costs associated with digital diabetes management devices and technologies
      • 3.2.2.2. Limited access to digital healthcare infrastructure in developing regions
  • 3.3. Digital Diabetes Management Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Digital Diabetes Management Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Digital Diabetes Management Product Market Movement Analysis
  • 4.3. Global Digital Diabetes Management Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Smart Glucose Meters
    • 4.4.1. Smart glucose meters market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Continuous Glucose Monitoring Systems
    • 4.5.1. Continuous glucose monitoring systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Smart Insulin Pens
    • 4.6.1. Smart insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Smart Insulin Pumps/Closed Loop Systems
    • 4.7.1. Smart insulin pumps/closed loop systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Apps
    • 4.8.1. Apps market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.8.1.1. Digital diabetes management apps
        • 4.8.1.1.1. Digital diabetes management apps market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.8.1.2. Weight & diet management apps
        • 4.8.1.2.1. Weight & diet management apps market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Digital Diabetes Management Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Digital Diabetes Management Type Market Movement Analysis
  • 5.3. Global Digital Diabetes Management Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Wearable Devices
    • 5.4.1. Wearable devices market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Handheld Devices
    • 5.5.1. Handheld devices market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Digital Diabetes Management Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Digital Diabetes Management End Use Market Movement Analysis
  • 6.3. Global Digital Diabetes Management Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Home Settings
    • 6.5.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Diagnostic Centers
    • 6.6.1. Diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Digital Diabetes Management Market: Regional Estimates & Trend Analysis By Product, Type, End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement structure
      • 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement structure
      • 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement structure
      • 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement structure
      • 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement structure
      • 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement structure
      • 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement structure
      • 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement structure
      • 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement structure
      • 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement structure
      • 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement structure
      • 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement structure
      • 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement structure
      • 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement structure
      • 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement structure
      • 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2024
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 8.6. Company Profiles
    • 8.6.1. Abbott
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Medtronic
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. F. Hoffmann-La Roche Ltd.
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Bayer AG
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. LifeScan, Inc.
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Dexcom, Inc.
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. Sanofi
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. Insulet Corporation
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. Ascensia Diabetes Care Holdings AG
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives
    • 8.6.10. B. Braun Melsungen AG
      • 8.6.10.1. Company overview
      • 8.6.10.2. Financial performance
      • 8.6.10.3. Product benchmarking
      • 8.6.10.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America digital diabetes management market, By country, 2018 - 2030 (USD Million)
  • Table 4. North America digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 5. North America digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 6. North America digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 7. U.S. digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 8. U.S. digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 9. U.S. digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 10. Canada digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 11. Canada digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 12. Canada digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 13. Mexico digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 14. Mexico digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 15. Mexico digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 16. Europe digital diabetes management market, By country, 2018 - 2030 (USD Million)
  • Table 17. Europe digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 18. Europe digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 19. Europe digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 20. UK digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 21. UK digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 22. UK digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 23. Germany digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 24. Germany digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 25. Germany digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 26. France digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 27. France digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 28. France digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 29. Italy digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 30. Italy digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 31. Italy digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 32. Denmark digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 33. Denmark digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 34. Denmark digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 35. Sweden digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 36. Sweden digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 37. Sweden digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 38. Norway digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 39. Norway digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 40. Norway digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 41. Asia Pacific digital diabetes management market, By country, 2018 - 2030 (USD Million)
  • Table 42. Asia Pacific digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 43. Asia Pacific digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 44. Asia Pacific digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 45. Japan digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 46. Japan digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 47. Japan digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 48. China digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 49. China digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 50. China digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 51. India digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 52. India digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 53. India digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 54. Australia digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 55. Australia digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 56. Australia digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 57. South Korea digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 58. South Korea digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 59. South Korea digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 60. Thailand digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 61. Thailand digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 62. Thailand digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 63. Latin America digital diabetes management market, By Country, 2018 - 2030 (USD Million)
  • Table 64. Latin America digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 65. Latin America digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 66. Latin America digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 67. Brazil digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 68. Brazil digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 69. Brazil digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 70. Argentina digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 71. Argentina digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 72. Argentina digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 73. Middle East & Africa digital diabetes management market, By country, 2018 - 2030 (USD Million)
  • Table 74. Middle East & Africa digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 75. Middle East & Africa digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 76. Middle East & Africa digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 77. South Africa digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 78. South Africa digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 79. South Africa digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 80. Saudi Arabia digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 81. Saudi Arabia digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 82. Saudi Arabia digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 83. UAE digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 84. UAE digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 85. UAE digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
  • Table 86. Kuwait digital diabetes management market, By product, 2018 - 2030 (USD Million)
  • Table 87. Kuwait digital diabetes management market, By type, 2018 - 2030 (USD Million)
  • Table 88. Kuwait digital diabetes management market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Digital diabetes management market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Digital diabetes management market driver impact
  • Fig. 19 Digital diabetes management market restraint impact
  • Fig. 20 Digital diabetes management market: Product movement analysis
  • Fig. 21 Digital diabetes management market: Product outlook and key takeaways
  • Fig. 22 Smart glucose meters market estimates and forecast, 2018 - 2030
  • Fig. 23 Continuous glucose monitoring systems market estimates and forecast, 2018 - 2030
  • Fig. 24 Smart insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 25 Smart insulin pumps/closed loop systems market estimates and forecast, 2018 - 2030
  • Fig. 26 Apps market estimates and forecast, 2018 - 2030
  • Fig. 27 Digital diabetes management apps market estimates and forecast, 2018 - 2030
  • Fig. 28 Weight & diet management apps market estimates and forecast, 2018 - 2030
  • Fig. 29 Digital diabetes management market: End-use movement analysis
  • Fig. 30 Digital diabetes management market: End-use outlook and key takeaways
  • Fig. 31 Hospitals market estimates and forecast, 2018 - 2030
  • Fig. 32 Home settings market estimates and forecast, 2018 - 2030
  • Fig. 33 Diagnostic centers market estimates and forecast, 2018 - 2030
  • Fig. 34 Global digital diabetes management market: Regional movement analysis
  • Fig. 35 Global digital diabetes management market: Regional outlook and key takeaways
  • Fig. 36 North America
  • Fig. 37 North America market estimates and forecasts, 2018 - 2030
  • Fig. 38 U.S.
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 40 Canada
  • Fig. 41 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 42 Mexico
  • Fig. 43 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 44 Europe
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 46 UK
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030
  • Fig. 48 Germany
  • Fig. 49 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 50 France
  • Fig. 51 France market estimates and forecasts, 2018 - 2030
  • Fig. 52 Italy
  • Fig. 53 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 54 Spain
  • Fig. 55 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 56 Denmark
  • Fig. 57 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 58 Sweden
  • Fig. 59 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 60 Norway
  • Fig. 61 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 62 Asia Pacific
  • Fig. 63 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 64 China
  • Fig. 65 China market estimates and forecasts, 2018 - 2030
  • Fig. 66 Japan
  • Fig. 67 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 68 India
  • Fig. 69 India market estimates and forecasts, 2018 - 2030
  • Fig. 70 Thailand
  • Fig. 71 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 72 South Korea
  • Fig. 73 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 74 Australia
  • Fig. 75 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 76 Latin America
  • Fig. 77 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 78 Brazil
  • Fig. 79 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 80 Argentina
  • Fig. 81 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 82 Middle East and Africa
  • Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 84 South Africa
  • Fig. 85 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 86 Saudi Arabia
  • Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 88 UAE
  • Fig. 89 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 90 Kuwait
  • Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 92 Market share of key market players- Digital diabetes management market